日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

JOSD2 inhibits angiotensin II-induced vascular remodeling by deubiquitinating and stabilizing SMAD7.

JOSD2 通过去泛素化和稳定 SMAD7 来抑制血管紧张素 II 诱导的血管重塑

Shen Si-Rui, Huang Zhu-Qi, Yang Yu-Die, Han Ji-Bo, Fang Zi-Min, Guan Yue, Xu Jia-Chen, Min Ju-Lian, Wang Yi, Wu Gao-Jun, Xiao Zhong-Xiang, Luo Wu, Huang Zhou-Qing, Liang Guang

Overview of Gas-Generating-Reaction-Based Immunoassays

基于气体发生反应的免疫分析概述

Yu, Zhao-Jiang; Deng, De-Hua; Liang, Si-Rui; Huang, Ya-Liang; Yi, Xin-Yao

The regulation of intestinal flora on host's genes may play an essential role in the development of endometrial hyperplastic processes in yang deficiency individuals

肠道菌群对宿主基因的调控可能在阳虚个体子宫内膜增生的发生发展中起着至关重要的作用。

Zhang, Hui-Xiang; Zhao, Xiao-Ling; Wu, Hong-Xiang; Luo, Zhan-Qin; Wang, Li-Mei; Lv, Si-Rui; Huang, Xue-Rong; Dong, Nan; Li, Dai-Zhu; Bao, Chan; Su, Liang-Di; Liu, Ying-Xiu; Hu, Hui-Qiong; Bu, Zi-Xian; Zhang, Hao-Ran; Liu, Ying; Chang, Shu-Jie; He, Zheng-Yuan; Sai, Liang; Wang, Hua-Wei; Guo, Hui-Ming; Huang, Xue-Hui; Cao, Xue

Case report: Remarkable response to sintilimab, lenvatinib, and nab-paclitaxel in postoperative metastatic chemotherapy-resistant combined hepatocellular-cholangiocarcinoma

病例报告:术后转移性化疗耐药的混合型肝细胞癌-胆管癌对信迪利单抗、乐伐替尼和白蛋白紫杉醇治疗反应显著

Zhou, Nan; Lei, Chuan-Fen; Tan, Si-Rui; Huang, Qi-Yue; Zhang, Shun-Yu; Liang, Zheng-Xin; Gou, Hong-Feng

GSPT1 Functions as a Tumor Promoter in Human Liver Cancer

GSPT1 在人类肝癌中发挥肿瘤促进作用

Yi-Qing Xi #, Jing-Bo Gao #, Xuan-Fei Li #, Li-Hua Xu, Zhi Li, Li-Jie Yang, Jing Wang, Hua-Qiao Wang, Xiao-Chang Fang, Si-Rui Huang, Wei Xie, Mao-Hui Feng, Jing-Wei Zhang

GMFG Has Potential to Be a Novel Prognostic Marker and Related to Immune Infiltrates in Breast Cancer

GMFG 有可能成为一种新型预后标志物,并且与乳腺癌的免疫浸润有关

Yan Yang, Xin He, Qian-Qian Tang, You-Cheng Shao, Wen-Jing Song, Peng-Ju Gong, Yi-Fan Zeng, Si-Rui Huang, Jiang-Yao Zhou, Hui-Fang Wan, Lei Wei, Jing-Wei Zhang